XML 83 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating Expenses:    
Research and development $ 41,676 $ 37,196
General and administrative 12,290 13,528
Total operating expenses 53,966 50,724
Loss from operations (53,966) (50,724)
Other income (expense):    
Grant income 19,549 24,805
Other income, net 666 158
Interest expense (25) (27)
Loss on currency translation from liquidation of subsidiary (195)  
Total other income, net 19,995 24,936
Net loss (33,971) (25,788)
Foreign currency translation adjustment, including reclassifications 195 4
Total comprehensive loss $ (33,776) $ (25,784)
Net loss per share, basic (in dollars per share) $ (0.86) $ (0.86)
Net loss per share, diluted (in dollars per share) $ (0.86) $ (0.86)
Weighted-average common shares outstanding, basic (in shares) 39,730,148 30,029,087
Weighted-average common shares outstanding, diluted (in shares) 39,730,148 30,029,087